Journal of Geriatric Oncology, published by Elsevier, stands at the intersection of geriatric medicine and oncology, addressing the unique needs and challenges of cancer management in older adults. Since its inception in 2010, this esteemed journal has played a pivotal role in advancing research and clinical practices, aiming to improve the quality of life and treatment outcomes for elderly cancer patients. With its impressive categorization in the 2023 Q2 quartile for both Geriatrics and Gerontology and Oncology, the journal demonstrates a noteworthy impact within its fields, ranking #153 out of 404 in Medicine – Oncology and #45 out of 116 in Medicine – Geriatrics and Gerontology. Researchers and healthcare professionals are encouraged to access critical insights through its rigorous peer-reviewed articles, which offer cutting-edge research findings and clinical applications. As the field continues to evolve, the Journal of Geriatric Oncology remains a vital resource for those dedicated to fostering innovation in geriatric oncology.

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

Current Oncology Reports is a prestigious academic journal dedicated to the field of oncology, published by Springer and based in the United States. With an impressive impact factor and ranking as a Q1 journal in the 2023 category of Oncology, it positions itself among the top-tier publications within the discipline. Established in 1999, the journal has been a vital resource for researchers, professionals, and students alike, providing comprehensive insights and the latest advancements in cancer research and treatment. Through its rigorous peer-review process, Current Oncology Reports disseminates high-quality original articles, reviews, and clinical studies that foster collaboration and innovation in the oncology community. Although it currently operates under a subscription model, the journal remains committed to accessibility, ensuring that critical findings reach a broad audience. As such, it serves as an essential platform for those dedicated to the fight against cancer, making significant contributions to the evolving landscape of oncology.

Neuro-Oncology Practice is a leading journal in the interdisciplinary field of neuro-oncology, published by Oxford University Press. With an ISSN of 2054-2577 and E-ISSN 2054-2585, this journal provides a critical platform for the dissemination of cutting-edge research and clinical advancements since its inception in 2014. As of 2023, it has achieved a Q2 ranking in Medicine (Miscellaneous), Neurology, and Oncology categories, reflecting its esteemed position in the academic community with impressive Scopus rankings, including a 74th percentile in the field of Medicine. Despite its non-open access status, Neuro-Oncology Practice aims to bridge the gap between laboratory research and clinical practice, offering valuable insights for professionals involved in the treatment and study of neurological cancers. The journal actively encourages submissions that explore innovative treatment strategies, enhance patient care, and advance our understanding of the complexities surrounding brain tumors. With a convergence period extending to 2024, it remains a crucial resource for researchers, practitioners, and students who are committed to improving outcomes in the field of neuro-oncology.

SUPPORTIVE CARE IN CANCER is a premier academic journal published by Springer, dedicated to advancing the understanding and management of supportive care for cancer patients. With a notable impact factor, the journal is recognized for its contribution to the fields of Oncology, Rehabilitation, and Nursing, achieving impressive rankings in Scopus, including Q1 for Oncology Nursing and Rehabilitation, and Q2 for general Oncology. Founded in 1993 and looking towards a promising future until 2024, it serves as a vital resource for researchers, professionals, and students engaged in these critical areas of healthcare. Although not an Open Access journal, its rigorous peer-reviewed articles provide valuable insights into innovative practices and evidence-based strategies that enhance patient quality of life during and after treatment. By bridging the gap between research and clinical practice, SUPPORTIVE CARE IN CANCER significantly influences patient outcomes and fosters interdisciplinary collaboration in patient support.

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

Palliative Medicine Reports, published by MARY ANN LIEBERT, INC, is an esteemed Open Access journal dedicated to advancing the field of palliative care and pain management. Since its inception in 2020, this journal has established itself as an important platform for researchers and practitioners in the domains of Advanced and Specialized Nursing, Anesthesiology, and Pain Medicine. With an impressive Q2 ranking in both Advanced and Specialized Nursing and Anesthesiology and Pain Medicine, and a Q3 ranking in the Health (Social Science) category, it stands out as a reputable resource for disseminating high-quality research. The journal fosters an interdisciplinary approach, aiming to bridge gaps in knowledge and practice related to palliative care and the holistic needs of patients experiencing serious illness. Researchers, clinicians, and scholars are encouraged to contribute their work, benefitting from the journal's broad visibility and rigorously peer-reviewed process, ensuring that critical advancements in the field receive the attention they deserve.

Journal of Cancer Policy is an esteemed publication devoted to the critical intersection of health policy and oncology. Published by Elsevier Sci Ltd in the United Kingdom, this journal has been a pivotal platform since its inception in 2013, contributing to the field's discourse on cancer management and policy-making strategies. With an impressive Q2 ranking in both the Health Policy and Oncology categories for 2023, it underscores its significance in shaping policy frameworks that address the complexities of cancer care. The journal is listed in Scopus with a respectable rank of #177 in Health Policy and #261 in Oncology, indicating its broad reach and impactful contributions to research and scholarly discussions. While the journal operates under a subscription model, it aims to provide readers with high-quality research that can influence health decisions and policy formation. As a vital resource for researchers, healthcare professionals, and students alike, the Journal of Cancer Policy plays a fundamental role in advancing the understanding of how policies can improve cancer outcomes and healthcare systems.

The American Journal of Hospice & Palliative Medicine, published by SAGE Publications Inc, is a leading peer-reviewed journal dedicated to advancing the field of hospice and palliative medicine. With its ISSN 1049-9091 and E-ISSN 1938-2715, the journal has been a vital resource since its inception in 1984, aiming to provide comprehensive insights into clinical practices, innovations, and research findings that enrich the quality of life for patients with serious illnesses. It holds a prestigious position as a Q2 journal in the field of medicine (miscellaneous), ranked #139 out of 636 in General Medicine with an impressive 78th percentile standing according to Scopus. The journal does not currently operate under an Open Access model, ensuring rigorous review and quality control of its content. Researchers, clinicians, and students are encouraged to engage with the latest developments and evidence-based practices in palliative care as the journal continues to shape discussions and policies in this critical area of healthcare.

The Journal of Hospice & Palliative Nursing (ISSN: 1522-2179, E-ISSN: 1539-0705), published by Lippincott Williams & Wilkins, stands as a leading resource in the field of hospice and palliative care nursing. With an impressive impact factor and ranked in the Q1 quartile for Advanced and Specialized Nursing and Q2 quartile for Community and Home Care as of 2023, this journal serves as a critical platform for disseminating evidence-based practices and innovative research. It covers a broad spectrum of topics, aiming to improve patient experiences and enhance the quality of care for individuals with life-limiting conditions. Created to support healthcare professionals, researchers, and students in the United States and beyond, the journal invites contributions that stimulate scholarly dialogue and advance the practice of palliative nursing. With publication years converging from 1999 to 2024, it remains an invaluable asset to the nursing community, fostering advancements in this vital area of healthcare.